Editorial Comment on “Quantitative Assessment of Additive Effects of Mirabegron and Solifenacin in Overactive Bladder: Re-analysis of SYNERGY Study”

Urology 2026

View at publisher
Authors: Hann‐Chorng Kuo
DOI: 10.1016/j.urology.2026.07.030
Cited by: 1
References: 11

Publication details

Journal / source
Urology
Publisher
Elsevier BV
Volume
215
Pages
58–59
Publication date
23 July 2026
Language
EN